nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Analytical Methods for Comparing Uncontrolled Trials With External Controls From Real-World Data: A Systematic Literature Review and Comparison With European Regulatory and Health Technology Assessment Practice
|
Hogervorst, Milou A. |
|
|
28 |
1 |
p. 161-174 |
artikel |
2 |
An Attribution of Value Framework for Combination Treatments
|
Briggs, Andrew H. |
|
|
28 |
1 |
p. 72-80 |
artikel |
3 |
A Review and Comparative Case Study Analysis of Real-World Evidence in European Regulatory and Health Technology Assessment Decision Making for Oncology Medicines
|
Zong, Jihong |
|
|
28 |
1 |
p. 31-41 |
artikel |
4 |
Cancer Drug Wastage and Mitigation Methods: A Systematic Review
|
Rajangom, Krishna Sabareesh |
|
|
28 |
1 |
p. 148-160 |
artikel |
5 |
Challenges in Value Assessment for One-Time Gene Therapies for Inherited Retinal Diseases: Are We Turning a Blind Eye?
|
Hitch, Jake |
|
|
28 |
1 |
p. 116-124 |
artikel |
6 |
Deriving a Preference-Weighted Measure for People With Hypoglycemia From the Hypo-RESOLVE QoL
|
Rowen, Donna |
|
|
28 |
1 |
p. 125-137 |
artikel |
7 |
Development of a Health-State Classification System for the Pediatric Quality-of-Life Inventory Version 4.0 Generic Core Scales for Preference-Based Valuation in Australia
|
Kwon, Joseph |
|
|
28 |
1 |
p. 88-98 |
artikel |
8 |
Dysmenorrhea-Related Impact on Functioning Scale: Development and Measurement Properties for Cisgender Women and Transgender Men
|
Arruda, Guilherme T. |
|
|
28 |
1 |
p. 99-107 |
artikel |
9 |
Economic Evaluation of Fasting Mimicking Diet Versus Standard Care in Diabetic Patients on Dual or Triple Medications at Baseline in the United States: A Cost-Utility Analysis
|
Habka, Dany |
|
|
28 |
1 |
p. 51-59 |
artikel |
10 |
Editorial Board
|
|
|
|
28 |
1 |
p. v |
artikel |
11 |
Exploring Heterogeneity in the Cost-Effectiveness of High-Flow Nasal Cannula Therapy in Acutely Ill Children—Insights From the Step-Up First-line Support for Assistance in Breathing in Children Trial Using a Machine Learning Method
|
Hattab, Zaid |
|
|
28 |
1 |
p. 60-69 |
artikel |
12 |
Good Practices for Health Technology Assessment Guideline Development: A Report of the Health Technology Assessment International, HTAsiaLink, and ISPOR Special Task Force
|
Botwright, Siobhan |
|
|
28 |
1 |
p. 1-15 |
artikel |
13 |
Most Common Symptomatic Adverse Reactions of Cancer Treatments From US Drug Labels (2015-2021) to Inform Selection of Patient-Reported Outcomes
|
Horodniceanu, Erica G. |
|
|
28 |
1 |
p. 108-115 |
artikel |
14 |
Primer on Health Equity Research in Health Economics and Outcomes Research: An ISPOR Special Interest Group Report
|
Griffiths, Matthew J.S. |
|
|
28 |
1 |
p. 16-24 |
artikel |
15 |
Proposal for a General Outcome-Based Value Attribution Framework for Combination Therapies
|
Steuten, Lotte |
|
|
28 |
1 |
p. 81-87 |
artikel |
16 |
Table of Contents
|
|
|
|
28 |
1 |
p. i-iv |
artikel |
17 |
Unpaid Caring and Health-Related Quality of Life: Longitudinal Analysis of Understanding Society (the UK Household Longitudinal Survey)
|
Pennington, Becky M. |
|
|
28 |
1 |
p. 138-147 |
artikel |
18 |
Value Attribution for Combination Treatments: Two Potential Solutions for an Insoluble Problem
|
Ciani, Oriana |
|
|
28 |
1 |
p. 70-71 |
artikel |
19 |
Virtual/Mobile Overdose Response in Canada: A Social Return on Investment Analysis
|
Rioux, William |
|
|
28 |
1 |
p. 42-50 |
artikel |
20 |
Will the Institute for Clinical and Economic Review’s Shared Savings Approach Decrease Value-Based Prices Most for the Most Severe Diseases?
|
Shafrin, Jason |
|
|
28 |
1 |
p. 25-30 |
artikel |